Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo

BACKGROUND AND METHODS: Applications of the anticancer agent, ellipticine, have been limited by its hydrophobicity and toxicity. An efficient delivery system is required to exploit the enormous potential of this compound. Recently, EAK16-II, an ionic-complementary, self-assembling peptide, has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yan, Sadatmousavi, Parisa, Wang, Rong, Lu, Sheng, Yuan, Yong-fang, Chen, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396387/
https://www.ncbi.nlm.nih.gov/pubmed/22802684
http://dx.doi.org/10.2147/IJN.S31858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396387/
https://www.ncbi.nlm.nih.gov/pubmed/22802684
http://dx.doi.org/10.2147/IJN.S31858

Ejemplares similares